by Mohd Haider | Mar 7, 2026 | General
Dr. Vinay Prasad, head of the Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), which oversees vaccines and biotech drugs, is set to leave his position at the end of April, FDA Commissioner Marty Makary confirmed on...
by Mohd Haider | Mar 7, 2026 | General
In defiance of the Pentagon’s recent decision to designate Anthropic AI as a supply chain risk, Amazon (NASDAQ:AMZN) and Google (NASDAQ:GOOG) (NASDAQ:GOOGL) have announced they will continue to offer Anthropic’s AI technology to their clients, except for...
by Ananya Gairola | Mar 7, 2026 | General
A class-action lawsuit has accused prediction market platform Kalshi of refusing to pay millions of dollars to bettors who predicted Iran’s supreme leader would leave office before a March deadline. Lawsuit Alleges $54 Million In Unpaid Bets The lawsuit, filed...
by Avi Kapoor | Mar 7, 2026 | General
Samsara Inc (NYSE:IOT) posted better-than-expected earnings results for the fourth quarter on Thursday. Samsara reported revenue of $444.30 million versus estimates of $422.26 million, and adjusted earnings per share of 18 cents versus estimates of 13 cents....
by Ananya Gairola | Mar 7, 2026 | General
On Friday, Senate Minority Leader Chuck Schumer (D-N.Y.) warned that the conflict in the Middle East may be expanding after a report said Russia is sharing intelligence with Iran on U.S. military assets. Report Claims Russia Passed Targeting Data To Iran A report by...
by Ananya Gairola | Mar 7, 2026 | General
Novo Nordisk AS (NYSE:NVO) and Hims & Hers Health Inc. (NYSE:HIMS) have reportedly ended their public feud, with the drugmaker deciding to sell its weight-loss drug on the telehealth platform. The announcement regarding the new partnership is expected as soon as...
Recent Comments